[Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D011604:Psychoses, Alcoholic / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D012563:Schizophrenia, Paranoid / Q000188:drug therapy
D003692:Delayed-Action Preparations; D005476:Fluphenazine
Expérimentation au niveau du Centre de guidance d'Lxelles d'un neuroleptique majeur: l'anatensol décanoate